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Characterization of Cholesterol and Drug Ligand Interactions with Trans-
locator Protein 18 KDA (TSPO) from Rhodobacter Sphaeroides
Fei Li, Lance Valls, Shelagh Ferguson-Miller.
Biochemistry and Molecular Biology, Michigan State University, East
Lansing, MI, USA.
The mitochondrial outer membrane protein Translocator Protein 18 kDa
(TSPO), previously known as the peripheral benzodiazepine receptor (PBR),
has been proposed to be a key component of the cholesterol transport system
in mitochondria and a rate limiting step for steroidogenesis. Dysregulation of
neurosteroids generation involving TSPO has been shown to be related to a va-
riety of neurological and psychiatric diseases, including Alzheimer’s disease,
Parkinson’s disease, as well as bipolar disorder. In addition, ligands of TSPO
are widely used for imaging brain injury and inflammation, areas in which
TSPO is highly expressed. A natural human single-nucleotide polymorphism
(SNP) gives rise to a mutation, A147T, within the proposed cholesterol recog-
nition site (CRAC). This mutation leads to altered ligand binding and has
recently been reported to reduce pregnenolone production and to be associated
with bipolar disorder. The same mutation is reported to inhibit a proposed
TSPO catalyzed degradation of prototoporphyrin IX. TSPO from Rhodobacter
sphaeroides (RsTSPO) shares high sequence similarity with the human protein
but differs in the region of the SNP and shows significantly lower cholesterol
binding. To better understand the interaction of TSPO with cholesterol,
porphyrin and other ligands, we expressed and purified the recombinant
RsTSPO and several mutants in the cholesterol binding region. Binding prop-
erties were investigated with a sensitive tryptophan fluorescence quenching
assay and the interactions were characterized by X-ray crystallography.(Sup-
ported by the MSU Center for Mitochondrial Science and Medicine, a Strategic
Partnership Grant fromMichigan State University Foundation and GM26916 to
SFM).
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Monitoring Intramembrane Proteolytic Cleavage Reactions using Isotope-
Assisted Vibrational Interrogation of Membrane Embedded (IVIBE)
Proteins
Mia Brown1, Renee D. JiJi2, Iban Ubarretxena-Bilandia3, Jason W. Cooley2.
1University of Missouri Columbia, Columbia, MO, USA, 2Chemistry,
University of Missouri Columbia, Columbia, MO, USA, 3Icahn School of
Medicine at Mt. Sinai, New York City, NY, USA.
While several intramembrane cleaving proteases (iCliPs), enzymes that carry
out proteolysis reactions within the membrane interior, have had their struc-
tures solved, basic biochemical questions such as what determines a substrate
and how cleavage site is dictated remain. However, our inability to monitor
enzyme-substrate interactions in a lipid environment is the dominant factor
limiting our understanding of the central questions associated with these en-
zymes. Specifically, while there are many excellent techniques for the charac-
terization of membrane proteins, many of them are only amenable to steady
state measurements, require removal from the membrane, or are too low reso-
lution to offer detailed information about changes in structure and environment.
Here we offer a new method by which to observe structural fluctuations of the
enzyme and the substrate during cleavage reactions within a membrane envi-
ronment: isotope-assisted vibrational interrogation of bilayer-embedded sys-
tems (iVIBE). Deep UV resonance Raman (DUVRR) spectroscopy has
previously been used to observe structural and environmental changes in
both soluble and membrane proteins. Now, using an isotopically labeled prote-
ase and an unlabeled substrate we can resolve the spectral responses from each
protein, allowing us to observe the cleavage reaction over time and determine
the binding site, or structural fate of the substrate.
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Investigating Ligand-Modulation of GPCR Activation Pathways
Morgan Lawrenz1, Kai Kohlhoff2, Diwakar Shukla1, Greg Bowman3,
Russ Altman1, Vijay Pande1.
1Stanford University, Stanford, CA, USA, 2Google Inc, Mountain View, CA,
USA, 3University of California, Berkeley, Berkeley, CA, USA.
Molecular dynamics simulations can provide tremendous insight into atomistic
details of biological mechanisms, but micro- to milliseconds timescales are his-
torically only accessible on dedicated supercomputers. We demonstrate that
cloud computing is a viable alternative, bringing long timescale processes
within reach of a broader community. We used Google’s Exacycle cloud
computing platform to simulate an unprecedented 2 milliseconds of dynamics
of the b2 adrenergic receptor (b2AR)_a major drug target G protein-coupled
receptor (GPCR). Markov state models aggregating these independent simula-
tions into a single statistical model are validated by previous computational and
experimental results and provide the first atomistic description of multipleGPCR activation pathways. We show that agonists and inverse agonists interact
differentially with these pathways, creating an opportunity for developing
drugs that interact more closely with diverse receptor states, for overall
increased efficacy and specificity.
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Crystal Structure of MraY, an Essential Membrane Enzyme for Bacterial
Cell Wall Synthesis
Ben C. Chung, JInshi Zhao, Robert Gillespie, Do Yeon Kwon, Ziqiang Guan,
Jiyong Hong, Pei Zhou, Seok-Yong Lee.
Duke University, Durham, NC, USA.
The Phospho-MurNAc-pentapeptide translocase (MraY) is a prokaryotic
membrane-spanning enzyme involved in an essential process of peptidoglycan
synthesis: transfer the precursor phosphor-MurNAc-pentapeptide to carrier
lipid undecaprenyl phosphate. MraY belongs to a subfamily of the
polyprenyl-phosphate N-acetyl hexosamine 1-phosphate transferase (PNPT)
superfamily whose members are involved in various biological processes
including eukaryotic N-linked glycosylation. MraY has been a target for anti-
biotics development for its essentiality and specificity in bacteria. Therefore
atomic structure of MraY can provides valuable mechanistic information that
can aid development of new antibiotics. We report the crystal structure of
MraY from Aquifex aeolicus (MraYAA), the first structure of the PNPT super-
family, at 3.3 A˚ resolution. The crystal structure, together with crystallographic
and functional studies, reveals the architecture of MraYAA, the location of
Mg2þ at the active site and the putative binding sites of both substrates. Our
crystallographic studies provide insights into the mechanism of how MraY at-
taches a building block of peptidoglycan to a carrier lipid.
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Alexander Heifetz1, Oliver Barker1, G. Benjamin Morris2, Richard J. Law1,
Mark Slack3, Philip C. Biggin2.
1Evotec, Abingdon, United Kingdom, 2Oxford University, Oxford, United
Kingdom, 3Evotec, Hamburg, Germany.
Orexin-1 (OX1) and orexin-2 (OX2) are class A G-protein Coupled Receptors
(GPCR)s located predominantly in the brain and are linked to a range of
different physiological functions, including the control of energy metabolism
and regulation of the sleep-wake cycle. The natural agonists for both receptors
are two small peptides, Orexin A and Orexin B. Both peptides have activity at
both receptors. Although no experimentally-derived structure has yet been pub-
lished for the receptors in complex with either agonists or antagonists, a large
amount of site-directed mutagenesis (SDM) has been reported and has provided
important insight into the key determinants of agonist and antagonist activity.
In drug-discovery, a working three-dimensional model can provide an intuitive
way forward to explore new compounds. Thus we developed homology models
that utilized existing SDM data, which we then explored further with MD simu-
lation and ensemble-flexible docking to generate binding poses of the Orexin
peptides in the OX receptors. We were then able to test the resulting poses
with additional SDM experiments. As part of our modelling procedure we
also developed a new method to analyze the structural data generated within
an MD simulation to help distinguish between different GPCR substates. Our
work demonstrates how this new method of structural assessment for GPCRs
can be used to provide a working model for peptide-Orexin receptor
interaction.
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Kinetic Exclusion Analysis (KinExa) of Avidity Enhancement of a Multi-
Valent Adnectin Binding to Clustered Receptors on CHO Cells
Lumelle A. Schneeweis1, Sandra V. Hatcher1, Bryan Barnhart1,
Thomas R. Glass2, Lin Cheng1, Benjamin Blum3, Eric Lawrence1,
Rolf Ryseck1, Ray Camphausen3, Bozena M. Abramczyk1, Anthony Della
Pietra1, Martin J. Corbett1, Thomas McDonagh3, Michael L. Doyle1,
James Bryson1.
1Bristol-Myers Squibb, Princeton, NJ, USA, 2Sapidyne Instruments, Inc.,
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Multivalency is a strategy used in nature to gain avidity. A variety of cell sur-
face receptors are known to cluster at the cell surface via protein or lipid (raft)
interactions. Analytical methods to measure the effect of avidity as it exists at a
cell surface are challenging. Kinetic Exclusion Analysis (KinExA) is a sensi-
tive immunodetection analytical technique for measuring solution affinity. Ad-
nectinsTM are a proprietary type of targeted biologic derived from human
fibronectin. Adnectin-A was selected with mRNA display (PROfusionTM) to
bind specifically to cell surface receptor X, and was formated as a multivalent
fusion protein. To determine the affinity and avidity of Adnectin-A for receptor
X clustered on cells, both the human and cynomolgus monkey homoloques of
